Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
Rev Sci Instrum ; 87(2): 02B912, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26932084

ABSTRACT

Linac3 is the first accelerator in the heavy ion injector chain of the Large Hadron Collider (LHC), providing multiply charged heavy ion beams for the CERN experimental program. The ion beams are produced with GTS-LHC, a 14.5 GHz electron cyclotron resonance ion source, operated in afterglow mode. Improvement of the GTS-LHC beam formation and beam transport along Linac3 is part of the upgrade program of the injector chain in preparation for the future high luminosity LHC. A mismatch between the ion beam properties in the ion source extraction region and the acceptance of the following Low Energy Beam Transport (LEBT) section has been identified as one of the factors limiting the Linac3 performance. The installation of a new focusing element, an einzel lens, into the GTS-LHC extraction region is foreseen as a part of the Linac3 upgrade, as well as a redesign of the first section of the LEBT. Details of the upgrade and results of a beam dynamics study of the extraction region and LEBT modifications will be presented.

2.
Rev Sci Instrum ; 85(2): 02A729, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24593463

ABSTRACT

Linac4, a 160 MeV normal-conducting H(-) linear accelerator, is the first step in the upgrade of the beam intensity available from the LHC proton injectors at CERN. The Linac4 Low Energy Beam Transport (LEBT) line from the pulsed 2 MHz RF driven ion source, to the 352 MHz RFQ (Radiofrequency Quadrupole) has been built and installed at a test stand, and has been used to transport and match to the RFQ a pulsed 14 mA H(-) beam at 45 keV. A temporary slit-and-grid emittance measurement system has been put in place to characterize the beam delivered to the RFQ. In this paper a description of the LEBT and its beam diagnostics is given, and the results of beam emittance measurements and beam transmission measurements through the RFQ are compared with the expectation from simulations.

3.
Rev Med Chir Soc Med Nat Iasi ; 104(2): 143-9, 2000.
Article in Romanian | MEDLINE | ID: mdl-12089980

ABSTRACT

The risk to developing a neoplasm is increased when associated to a patient phakomatosis (Recklinghausen neurofibromatosis, Bourneville's tuberous sclerosis). We analysed 6 cases with phakomatosis and tumours, admitted in the Department of Oncopediatry, between 1993-1998; five of these children had neurofibromatosis and one Bourneville's disease. The associated tumours were hematologic malignancies (juvenile myeloid chronic leukemia) and solid tumors (rhabdomyosarcoma, hepatic carcinoma, CNS tumour, NHL optic glioma). The diagnosis was confirmed by microscopic examination of the bioptic material in all cases. Tumoral staging was performed by clinics, biology and imagistic investigations. All cases had extensive and aggressive tumours at the moment of diagnosis, We noticed a poor response and an early relapse after chemotherapy. A special follow-up and a different management has to be established for the patients with phakomatosis, in order to have a good oncological prophylaxis.


Subject(s)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Neurofibromatosis 1/complications , Orbital Neoplasms/complications , Rhabdomyosarcoma/complications , Tuberous Sclerosis/complications , Adolescent , Child , Child, Preschool , Fatal Outcome , Female , Follow-Up Studies , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Male , Neoplasm Staging , Neurofibromatosis 1/diagnosis , Neurofibromatosis 1/therapy , Orbital Neoplasms/diagnosis , Orbital Neoplasms/therapy , Rhabdomyosarcoma/diagnosis , Rhabdomyosarcoma/therapy , Tuberous Sclerosis/diagnosis , Tuberous Sclerosis/therapy
4.
Am J Pathol ; 147(4): 1001-15, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7573346

ABSTRACT

The present study examined the temporal pattern and localization of interleukin-1, tumor necrosis factor-alpha, and inducible nitric oxide synthase expression in lung tissue undergoing foreign body granuloma formation. Pulmonary granulomas were induced by the intratracheal injection of dextran beads into genetically high granuloma responder, carrying Bcgs (BALB/c), and low responder, carrying Bcgr (C3H/HeJ and DBA/2), mice. There was a pattern of sequential expression of these molecules in BALB/c mice. Thus, interleukin-1 alpha and inducible nitric oxide synthase were induced mostly in the cells accumulated around the beads and also in some bronchiolar epithelial cells during the early phase (1 to 3 days), whereas tumor necrosis factor-alpha was induced in the cells around the beads at the later resolution phase (3 to 7 days). By contrast, in low responder mice, an increase in the expression of interleukin-1 alpha and inducible nitric oxide synthase was detected in lung macrophages as well as in alveolar cells and bronchiolar epithelial cells on day 1, but that of tumor necrosis factor-alpha was not detected throughout the period. These results together with our previous findings on cytokine activity in granuloma extract suggest that interleukin-1 and nitric oxide produced by recruited macrophages may take part in the early, macrophage-dependent phase of granuloma formation whereas tumor necrosis factor-alpha may be more crucial as a mediator responsible for the difference in innate resistance or susceptibility to granuloma formation.


Subject(s)
Granuloma/metabolism , Interleukin-1/biosynthesis , Lung Diseases/metabolism , Nitric Oxide Synthase/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Animals , Dextrans , Enzyme Induction , Female , Granuloma/etiology , Interleukin-1/genetics , Lung Diseases/etiology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred DBA , Microspheres , RNA, Messenger/metabolism , Rats , Time Factors , Tissue Distribution , Tumor Necrosis Factor-alpha/genetics
5.
J Ethnopharmacol ; 47(3): 135-43, 1995 Jul 28.
Article in English | MEDLINE | ID: mdl-8569237

ABSTRACT

The effect of a water-soluble derivative (WSD) of propolis on the classical pathway (CP) and the alternative (AP) complement activity has been investigated. The in vitro experiments show that WSD inhibits both pathways and the effect depends on the source of complement. The suppression of complement-mediated haemolysis proves to be time- and temperature-related. High WSD concentrations cause direct damage of the target erythrocytes. The estimation of C3-residual activity indicates that the preparation diminishes C3 functional activity.


Subject(s)
Complement C3/antagonists & inhibitors , Complement Inactivator Proteins/pharmacology , Propolis/pharmacology , Animals , Buffers , Complement Hemolytic Activity Assay , Dose-Response Relationship, Drug , Erythrocytes/drug effects , Guinea Pigs , Hemolysis/drug effects , Humans , Mice , Propolis/chemistry , Solubility , Water/chemistry
6.
J Ethnopharmacol ; 47(3): 145-7, 1995 Jul 28.
Article in English | MEDLINE | ID: mdl-8569238

ABSTRACT

The water soluble derivative (WSD) of propolis in a dose of 150 mg/kg was administered intravenously (i.v.), intraperitoneally (i.p.) and orally (p.o.) to mice. The alteration of serum alternative pathway (AP) complement level was observed. The WSD also influenced the process of acute inflammation provoked by zymosan in mice. The effect was strongly dependent on the route of WSD administration.


Subject(s)
Adjuvants, Immunologic/pharmacology , Complement Pathway, Alternative/drug effects , Propolis/pharmacology , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/therapeutic use , Administration, Oral , Animals , Complement Hemolytic Activity Assay , Edema/drug therapy , Female , Hindlimb , Inflammation/chemically induced , Inflammation/drug therapy , Injections, Intraperitoneal , Injections, Intravenous , Male , Mice , Mice, Inbred ICR , Propolis/administration & dosage , Propolis/therapeutic use , Solubility , Water/chemistry , Zymosan/administration & dosage , Zymosan/toxicity
7.
Acta Microbiol Bulg ; 29: 29-38, 1993.
Article in English | MEDLINE | ID: mdl-8511995

ABSTRACT

The effect of experimental bovine herpes virus (BHV) type I rhinotracheitis on the surfactant system phospholipids in calves was examined. A stimulated exocytosis of pulmonary surfactant phospholipids in the acute phase of the disease was documented biochemically and ultrastructurally. The data presented were assumed as an evidence of the involvement of pulmonary surfactant in lung defense.


Subject(s)
Infectious Bovine Rhinotracheitis/metabolism , Lipid Metabolism , Pulmonary Surfactants/metabolism , Animals , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/metabolism , Cattle , Chromatography, Gas , Chromatography, Thin Layer , Lipids/analysis , Male , Pulmonary Surfactants/analysis , Time Factors
8.
Acta Microbiol Bulg ; 29: 39-46, 1993.
Article in English | MEDLINE | ID: mdl-8511997

ABSTRACT

Studies on the luminol-dependent chemiluminescent activity of rat peritoneal macrophages after in vitro interactions with E. coli WF+ L-form cells, their cytoplasmic membranes (CM) or parent bacterial cells were carried out. It was established that the phagocytosis of CM induce 20 time stronger light emission as compared to the L-form and 40 times compared to the parent bacterium cells respectively. Electron microscopical investigation of ultrathin sections of rat peritoneal macrophages after 24 h interaction in vitro with CM showed activation of the cell surfaces and vacuolisation of the cytoplasm. Inhibition of the phagolysosome fusion during phagocytosis of CM was observed. The mechanism of the immunostimulating activity of CM is discussed.


Subject(s)
Escherichia coli/immunology , L Forms/immunology , Macrophages/metabolism , Phagocytosis , Animals , Cell Fractionation/methods , Cell Membrane/immunology , Luminescent Measurements , Macrophages/immunology , Macrophages/ultrastructure , Microscopy, Electron , Peritoneal Cavity/cytology , Rats , Rats, Wistar
10.
Acta Microbiol Bulg ; 30: 25-31, 1993.
Article in English | MEDLINE | ID: mdl-8285129

ABSTRACT

The preliminary application of the preparation Oxadiarrhot has no effect on the progress and the result of bacterial and mixed (bacterial-viral) infections. In animals treated with the preparation antigen-reactive and antibody-productive cells show insignificant decrease in number. There is no essential influence of the preparation on the mononuclear phagocytes system--the alveolar macrophages and polymorphonuclears do not change their functions.


Subject(s)
Antiviral Agents/pharmacology , Immune System/drug effects , Oxazines/pharmacology , Animals , Antiviral Agents/therapeutic use , Drug Evaluation, Preclinical , Guinea Pigs , Immune System/immunology , Immunity, Cellular/drug effects , Influenza A virus , Klebsiella Infections/drug therapy , Klebsiella Infections/immunology , Klebsiella pneumoniae , Mice , Orthomyxoviridae Infections/drug therapy , Orthomyxoviridae Infections/immunology , Oxazines/therapeutic use , Phagocytosis/drug effects , Rats , Rats, Wistar
11.
Basic Life Sci ; 59: 717-28, 1992.
Article in English | MEDLINE | ID: mdl-1417697

ABSTRACT

Three Bulgarian medicinal plants--Geranium macrorrhizum L. and G. sanguineum L. (Geraniaceae), and Epilobium hirsutum L. (Onagraceae) were analyzed phytochemically. Different polyphenols like flavonoids and tannis have been found to be principal constituents of the plants. A series of water or alcohol extracts was obtained, and their anti-infectious activity was tested. A significant inhibitory effect of water-alcohol extract and of four fractions from the polyphenolic mixture of E. hirsutum on the reproduction of influenza viruses in vitro, in ovo, and in vivo was established. Four extracts from G. macrorrhizum and three extracts from G. sanguineum were studied for in vitro inhibition of the growth of some Gram-negative bacteria (Klebsiella pneumoniae, Proteus vulgaris, Escherichia coli, Pseudomonas aeruginosa), Gram-positive bacterium (Staphylococcus aureus), and fungus (Candida albicans). Some geranium extracts caused a strong increase of the survival rate in an infection with K. pneumoniae in mice. Augmentation of the nonspecific host resistance in relation to the influence of the extracts on the classical complement activation pathway was also studied.


Subject(s)
Anti-Infective Agents/pharmacology , Flavonoids , Phenols/pharmacology , Plants, Medicinal/chemistry , Polymers/pharmacology , Animals , Anti-Bacterial Agents , Anti-Infective Agents/isolation & purification , Antifungal Agents/isolation & purification , Antifungal Agents/pharmacology , Antiviral Agents/isolation & purification , Antiviral Agents/pharmacology , Bacterial Infections/drug therapy , Bulgaria , Chick Embryo , Complement Activation , Influenza A virus/drug effects , Mice , Mice, Inbred ICR , Mycoses/drug therapy , Orthomyxoviridae Infections/drug therapy , Phenols/isolation & purification , Polymers/isolation & purification , Polyphenols
12.
Vaccine ; 10(12): 817-23, 1992.
Article in English | MEDLINE | ID: mdl-1455907

ABSTRACT

The efficacy of the water-soluble derivative (WSD) of natural propolis (bee glue) was examined for augmentation of host resistance against experimental infections caused by Gram-negative pathogens (Klebsiella pneumoniae, Proteus vulgaris, Escherichia coli, Pseudomonas aeruginosa). The substance was found to induce significant non-specific protection, but did not inhibit the in vitro growth of the same strains. Pretreatment with WSD prior to the standard scheme for tumour necrosis factor (TNF) induction (BCG and two weeks later lipopolysaccharide (LPS)) provoked an interval-dependent reduction in the lytic capacity of serum against L 929 target cells. The replacement of the triggering or priming signal with WSD markedly increased TNF production. In vivo administration of WSD led to a rapid and route-dependent change in the alternative complement pathway haemolysis. The alteration in C1q complement component and total protein synthesis, and also in nitroblue tetrazolium reduction, suggests that macrophage activation makes a major contribution to the capacity of WSD to prevent infections.


Subject(s)
Adjuvants, Immunologic , Gram-Negative Bacteria/drug effects , Gram-Negative Bacterial Infections/prevention & control , Propolis/pharmacology , Animals , BCG Vaccine/immunology , Cells, Cultured , Complement Activation , Gram-Negative Bacterial Infections/immunology , Lipopolysaccharides/immunology , Macrophages/immunology , Mice , Mice, Inbred ICR , Neutrophils/immunology , Tumor Necrosis Factor-alpha/biosynthesis
13.
Acta Microbiol Bulg ; 25: 46-53, 1990.
Article in Bulgarian | MEDLINE | ID: mdl-2382594

ABSTRACT

The changes in the immune status of the calves infected with bovine herpes virus-1 inducing infectious rhinotracheitis were studied. The virus was introduced by intratracheal inoculation of 5 cm3 suspension with minimal concentration of 10(-7) CPU50 per 1 cm2 from the Cervena voda strain cultivated in calf kidney culture. An infection of moderate seriousness and characteristic clinical manifestations was caused. On the 2nd, 5th, 10th and 15th day after the infection lung lavage was carried out and samples were taken from the peripheral blood. The number, viability and differential distribution of the alveolar macrophages and phagocytic and microbicidal ability showed a tendency to decrease during the acute phase of the infection (the 2nd-5th day) followed by a slow restoration in the period of convalescence (the 15th day). Some parameters of the systemic immunity--number of the plaque-forming and the rosette-forming cells, differential and absolute number of leucocytes in the peripheral blood--also had similar dynamics. The changes in the local and in the systemic, in the cell and humoral immunity were connected to the pathogenesis of the infection and the immune suppressive properties of the agent. The rhinotracheitis infection is indicative of the character of changes in the immune status at herpes virus infections and, on the other hand, it can be used as a model for testing immunostimulators of recovery effect.


Subject(s)
Immune Tolerance/immunology , Infectious Bovine Rhinotracheitis/immunology , Animals , Antibody Formation/immunology , Cattle , Female , Immunity, Cellular/immunology , Leukocyte Count/veterinary , Macrophages/immunology , Male , Pulmonary Alveoli/immunology , Rosette Formation , Viral Plaque Assay
14.
Acta Microbiol Bulg ; 26: 10-8, 1990.
Article in Bulgarian | MEDLINE | ID: mdl-2097882

ABSTRACT

The immunostimulating antiviral preparation suramin has a favourable effect on the process and outcome of an experimental infection with the virus of infectious rhinotracheitis (bovine herpes virus type 1, BHV1), thus reducing the gravity of the clinical course and increasing the survival rate. The therapeutic protective effect of the preparation is expressed in the prevention of virus-induced immunosuppression which is markedly strong during the acute phase of the infection process. Suramin restored the number, viability, relative share in the bronchial lavage population, phagocytic and microbicidal capacity of the alveolar macrophages--a major factor of the local defence mechanisms of the lung. In a similar way suramin influenced some parameters of the systemic immunity (number and differential count of polymorphonuclear phagocytes, plaque- and rosette-forming cells). The application of suramin in doses lower than those used for virus inhibition and its considerable action on different mechanisms of the immune system suggested that the preparation's therapeutic effect could be related mainly to its immunostimulating properties.


Subject(s)
Adjuvants, Immunologic , Infectious Bovine Rhinotracheitis/drug therapy , Suramin/therapeutic use , Animals , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Cattle , Drug Evaluation, Preclinical , Infectious Bovine Rhinotracheitis/immunology , Macrophages/drug effects , Macrophages/immunology , Neutrophils/drug effects , Neutrophils/immunology
15.
Drug Metab Dispos ; 18(1): 107-14, 1990.
Article in English | MEDLINE | ID: mdl-1970769

ABSTRACT

The metabolism of prostaglandin F2 alpha (PGF2 alpha) in ewes was studied after im injection of 9 beta-3H-labeled PGF2 alpha. About 75% of injected radioactivity was excreted in urine within 6 hr, whereas less than 1% was excreted in the milk over 3 days. Most identified urinary metabolites were formed through well known reactions involving oxidation of the hydroxyl group at carbon 15, saturation of double bonds, and oxidation of both carbon chains. However, some metabolites underwent more extensive oxidation of the carbon chain than had been seen before in other species. This might have taken place through catabolic activity of the gastrointestinal microflora followed by reabsorption into the circulation.


Subject(s)
Dinoprost/metabolism , Animals , Biotransformation , Chromatography, Gas , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Dinoprost/pharmacokinetics , Dinoprost/urine , Female , Gas Chromatography-Mass Spectrometry , Milk/analysis , Oxidation-Reduction , Sheep
19.
Drug Metab Dispos ; 14(4): 494-502, 1986.
Article in English | MEDLINE | ID: mdl-2873999

ABSTRACT

Following iv and vaginal administration of (5,6-3H2)-ONO-802 (5,6-3H2-16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester) the appearance of radiolabeled compounds in plasma and urine were studied in early pregnant patients. Following iv administration, ONO-802 was rapidly hydrolyzed to the free acid which disappeared from plasma with an approximate half-life of 10-15 min. About 50% of the injected amount of compound was excreted in urine during the first 24 hr after injection. The structures of 16 urinary metabolites were determined. These data demonstrated that, following hydrolysis of ONO-802 to the free acid, the latter can undergo beta- and omega-oxidation like other prostaglandin analogs where enzymatic attack of the 15-hydroxyl group has been blocked. Some of the metabolites were excreted as conjugates (sulfates, glucuronides?) and, in two, the oxo group at C-9 had been reduced to a hydroxyl. Following vaginal administration of ONO-802 (1 mg, 60 microCi) in suppository form, radioactivity corresponding to 100-200 pg/ml of ONO-802 equivalents was found in plasma. The profile of metabolites in urine was qualitatively very similar to that after iv injection of (5,6-3H2)-ONO-802. Based on the data on excretion of metabolites in urine it was calculated that 12-28% of the dose administered vaginally was resorbed into the circulation.


Subject(s)
Alprostadil/analogs & derivatives , Alprostadil/blood , Alprostadil/metabolism , Alprostadil/urine , Chromatography, High Pressure Liquid , Female , Gas Chromatography-Mass Spectrometry , Gases , Humans , Injections, Intravenous , Metabolic Clearance Rate , Pregnancy , Suppositories , Vagina/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...